Currently, there are 64.48M common shares owned by the public and among those 56.06M shares have been available to trade.
The company’s stock has a 5-day price change of 37.71% and -10.70% over the past three months. GLYC shares are trading 44.18% year to date (YTD), with the 12-month market performance down to -88.34% lower. It has a 12-month low price of $0.14 and touched a high of $3.36 over the same period. GLYC has an average intraday trading volume of 955.49K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 31.52%, 36.05%, and 30.78% respectively.
Institutional ownership of GlycoMimetics Inc (NASDAQ: GLYC) shares accounts for 42.40% of the company’s 64.48M shares outstanding.
It has a market capitalization of $23.16M and a beta (3y monthly) value of 1.82. The earnings-per-share (ttm) stands at -$0.59. Price movements for the stock have been influenced by the stock’s volatility, which stands at 14.52% over the week and 9.95% over the month.
Analysts forecast that GlycoMimetics Inc (GLYC) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0.
CapitalOne coverage for the GlycoMimetics Inc (GLYC) stock in a research note released on December 22, 2023 offered a Overweight rating with a price target of $12. Jefferies was of a view on November 12, 2021 that the stock is Buy, while ROTH Capital gave the stock Buy rating on November 14, 2019, issuing a price target of $12. SunTrust on their part issued Hold rating on August 05, 2019.
